Dennis P. Wolf - 21 Nov 2025 Form 4 Insider Report for CODEXIS, INC. (CDXS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Nov 2025, 16:18:50 UTC
Prior SEC filing
12 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Georgia Erbez, as Attorney-in-Fact for Dennis Wolf

Key filing fact

Dennis P. Wolf filed Form 4 for CODEXIS, INC. (CDXS) on 25 Nov 2025.

Key facts

  • This page summarizes Dennis P. Wolf's Form 4 filing for CODEXIS, INC. (CDXS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Nov 2025, 16:18.

Change

  • Previous filing in this sequence was filed on 12 Jun 2025.
  • Current net transaction value: -$13,988.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001227560 Primary reporting owner

WOLF DENNIS P

Relationship
Director
Address
C/O CODEXIS, INC., 200 PENOBSCOT DRIVE, REDWOOD CITY
Signature
/s/ Georgia Erbez, as Attorney-in-Fact for Dennis Wolf
Signature date
25 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDXS transaction

Common Stock

Sale

Transaction value
$13,988
Shares
-8,952
Change %
-6.1%
Price
$1.56
Shares after
138,951
Date
21 Nov 2025
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This transaction was executed in multiple trades in prices ranging from $1.55 to $1.615, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F2

Includes 40,983 restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .